Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease-Reference-Cited by-同舟云学术

Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease

Published:2024-04-17 Issue:9 Volume:16 Page:581-595
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Lusetti Francesca¹²,D'Amico Ferdinando¹,Allocca Mariangela¹,Furfaro Federica¹,Zilli Alessandra¹,Fiorino Gionata¹³,Parigi Tommaso Lorenzo¹,Radice Simona¹,Peyrin-Biroulet Laurent⁴⁵⁶⁷,Danese Silvio¹^ORCID

Affiliation:

1. Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, 20132 Milan, Italy

2. Gastroenterology Unit, Foundation Policlinico San Matteo IRCCS, University of Pavia, 27100 Pavia, Italy

3. IBD Unit, Department of Gastroenterology & Digestive Endoscopy, San Camillo-Forlanini Hospital, 00152 Rome, Italy

4. Department of Gastroenterology, Nancy University Hospital, INSERM, NGERE, University of Lorraine F-54500 Vandœuvre-lès-Nancy, France

5. INFINY Institute, FHU-CURE, Nancy University Hospital, F-54500 Vandœuvre-lès-Nancy, France

6. Groupe Hospitalier privè Ambroise Parè – Hartmann, Paris IBD center, 92200 Neuilly sur Seine, France

7. Division of Gastroenterology & Hepatology, McGill University Health Center, H3A 0G4 Montreal, Quebec, Canada

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/imt-2023-0219

Reference66 articles.

1. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

2. Pathophysiology of Inflammatory Bowel Diseases

3. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

4. Crohn’s disease

5. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials;Journal of Gastroenterology;2024-07-09